Story at-a-glance –
- As early as March 2020, Dr. Vladimir Zelenko boasted a near-100% success rate treating COVID-19 patients with hydroxychloroquine (HCQ), azithromycin and zinc sulfate for five days
- Zelenko has now treated 3,000 patients with COVID-19 symptoms and only three high-risk patients have died
- Misinformation and outright lies were spun about HCQ, including fabricated research, in an apparent effort to suppress and prevent widespread use
- Early treatment is crucial. During the first five days of SARS-CoV-2 infection, the viral load remains fairly steady. Around Day 5, it exponentially increases, potentially overwhelming your immune system. To prevent complications, treatment needs to begin within the first five days of symptom onset
- Early treatment is also crucial to prevent “long-haul” symptoms after recovery. None of Zelenko’s patients who started their treatment within the first five days went on to develop long-haul symptoms
Many doctors around the world started using the anti-malaria drug hydroxychloroquine (HCQ) early on in the COVID-19 pandemic. Among them is Dr. Vladimir Zelenko, a practicing physician in a Jewish community in Monroe County, New York.
He garnered national attention in March 2020 when he told radio host Sean Hannity that he’d had a near-100% success rate treating COVID-19 patients with HCQ, azithromycin and zinc sulfate for five days.1 “I’ve seen remarkable results; it really prevents progression of disease, and patients get better,” he said at the time.